Neuronetics, Inc.
STIMNASDAQHealthcare● Active
$1.28
$-0.01(-0.78%)
Market Cap$89072384
P/E Ratio—
52W High$4.85
52W Low$0.8
Neuronetics, Inc. (STIM) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · STIM · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.15B | $0.07B | $0.07B | $0.07B | $0.06B |
| Cost of Revenue | $0.08B | $0.02B | $0.02B | $0.02B | $0.01B |
| Gross Profit | $0.07B | $0.05B | $0.05B | $0.05B | $0.04B |
| Gross Margin %(computed) | 48.48% | 72.32% | 72.47% | 76.26% | 78.93% |
| Operating Expenses | |||||
| R&D Expenses | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| G&A Expenses | $0.05B | $0.03B | $0.03B | $0.03B | $0.03B |
| Total Operating Expenses | $0.10B | $0.09B | $0.08B | $0.08B | $0.07B |
| Operating Income | ($0.03B) | ($0.03B) | ($0.03B) | ($0.04B) | ($0.03B) |
| Operating Margin %(computed) | -21.08% | -46.15% | -42.82% | -53.85% | -49.83% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Income Before Tax | ($0.04B) | ($0.04B) | ($0.03B) | ($0.04B) | ($0.03B) |
| Income Tax Expense | $0.00B | ($0.00B) | ($0.00B) | $0.00B | $0.00B |
| Net Income | ($0.04B) | ($0.04B) | ($0.03B) | ($0.04B) | ($0.03B) |
| Net Margin %(computed) | -26.15% | -58.36% | -42.31% | -56.99% | -56.39% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.59 | $-1.38 | $-1.05 | $-1.38 | $-1.22 |
| Wtd Avg Shares | 0.07B | 0.03B | 0.03B | 0.03B | 0.03B |
| EBITDA | ($0.03B) | ($0.03B) | ($0.02B) | ($0.03B) | ($0.03B) |
| EBITDA Margin %(computed) | -18.75% | -45.89% | -31.90% | -49.01% | -48.48% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Neuronetics, Inc. data
About Neuronetics, Inc. (STIM) Income Statement
Neuronetics, Inc. (STIM) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, STIM reported revenue of $0.15B, gross profit of $0.07B (gross margin 48.48%), and net income of ($0.04B) — a net profit margin of -26.15%.
Frequently asked questions
STIM · 4 questionsNeuronetics, Inc. (STIM) reported revenue of $0.15B for 2025, up 99.2% year-over-year.
STIM revenueSTIM salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09